- Volition to Take Part in Nu.Q® Vet Commercial Strategy Webinar
- Volition Announces Expansion of Availability of the Nu.Q® Vet Cancer Test Through IDEXX's Reference Laboratory Network
- Volition Issues Business Review 2022
- VolitionRx Limited Announces Third Quarter 2022 Financial Results and Business Update
- Volition Announces Clinical Research Study with Oncovet
- Volition to Participate in a Lung Cancer Screening Study in France
- VolitionRx Limited Schedules Third Quarter 2022 Earnings Conference Call and Business Update
More ▼
Key statistics
On Friday, VolitionRX Ltd (VNRX:ASQ) closed at 2.23, 70.23% above the 52 week low of 1.31 set on Sep 29, 2022.
52-week range
Markit short selling activity
Open | 2.34 |
---|---|
High | 2.39 |
Low | 2.23 |
Bid | 2.09 |
Offer | 2.41 |
Previous close | 2.35 |
Average volume | 112.82k |
---|---|
Shares outstanding | 57.52m |
Free float | 37.93m |
P/E (TTM) | -- |
Market cap | 135.18m USD |
EPS (TTM) | -0.5721 USD |
Data delayed at least 15 minutes, as of Feb 03 2023 21:10 GMT.
More ▼